Spero Therapeutics Competitors and Similar CompaniesClear all

Spero Therapeutics's competitors and similar companies include EnClear Therapies, MicrofluidX, CHF Solutions and Respicardia.
Spero Therapeutics
Spero Therapeutics
Spero Therapeutics is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections.
EnClear Therapies
EnClear Therapies
EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases.
MicrofluidX
MicrofluidX
MicrofluidX is a company that develops cell bioprocessing technology.
CHF Solutions
CHF Solutions
CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients.
Respicardia
Respicardia
Respicardia develops implantable therapies to improve respiratory and cardiovascular health.
Founding Date
Founding Date
2013
Founding Date
2018
Founding Date
2018
Founding Date
1999
Founding Date
2006
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Cambridge, US HQ
Locations
Newburyport, US HQ
Locations
HQ
Locations
Eden Prairie, US HQ
Locations
Hopkins, US HQ
Employees
Employees
5739% increase
Employees
12
Employees
563% decrease
Employees
6620% increase
Employees
941% decrease
Valuation ($)
Valuation ($)
70.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
34.5 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$103.8m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$8.9m (FY, 2023)
Revenue (est.)
N/A
Net income
Net income
$22.8m (FY, 2023)
Net income
N/A
Net income
N/A
Net income
($20.2m) (FY, 2023)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 10m (almost 5 years ago)
Latest funding round
$ 1.7m (over 4 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 121.5m
Total funding raised
$ 12m
Total funding raised
$ 1.7m
Total funding raised
$ 9m
Total funding raised
$ 149.1m
For sources of this data, please see the company profile

View Company Profiles

EnClear Therapies
HQ
Newburyport, US
Employees
12

EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases.

View company
MicrofluidX
HQ
Employees
56↓ 3% decrease

MicrofluidX is a company that develops cell bioprocessing technology.

View company
CHF Solutions
HQ
Eden Prairie, US
Employees
66↑ 20% increase

CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients.

View company
Respicardia
HQ
Hopkins, US

Respicardia develops implantable therapies to improve respiratory and cardiovascular health.

View company